Уважаемые пользователи!

Данный сайт содержит информацию для людей с медицинским образованием и специалистов здравоохранения.
Входя на сайт, Вы подтверждаете свое согласие с Условиями использования и Политикой конфиденциальности.



Dear visitor!
This site contains medical information for healthcare professionals.
You can go further, if you agree with Terms and Conditions and Privacy Policy on this site.

Faktory riska diabeticheskoy retinopatii

Cover Page

Abstract


Диабетическая ретинопатия (ДР) - позднее неспецифическое осложнение сахарного диабета (СД) 1 и 2 типов, представляющее собой поражение в сетчатки. На возникновение и прогрессирование ДР могут влиять разнообразные факторы, что объясняет большую вариабельность данных разных исследовательских групп, изучающих поражение сетчатки, вызванное диабетом.

Yulia Alexandrovna Trakhtenberg

ГОУ ДПО РМАЛО Росздрава, Москва

Tamara Miroslavovna Milen'kaya

Endocrinology Research Centre, Moscow

Alexander Sergeevich Ametov

ГОУ ДПО РМАЛО Росздрава, Москва

T Yu Demidova

ГОУ ДПО РМАЛО Росздрава, Москва

  1. Klein R, Klein BEK et al. The Wisconsin epidemiologic study of Diabetic Retinopathy. II,III // Arch Ophthalmol - 1984 - Vol.102 - P.50-56.
  2. Diabetes Control and Complication Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes // N.Eng.J.Med. - 1993 - Vol.329 - P.977-986.
  3. UK Prospective Diabetes Study (UKPDS) Group Intensive blood glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes // Lancet - 1998 - Vol.352 - P.837-853.
  4. Henricsson M, Groop L, Heijl A. et al. Progression of retinopathy after change of treatment from oral antihyperglycemic agents to insulin in noninsulin dependent diabetes // Invest. Ophthalmol. - 1995 - Vol.36 - S482
  5. Funatsu H,Yamashita H, Ohashi Y. Effect of rapid glicaemic control on progression of diabetic retinopathy // Jpn.J.Ophthalmol. - 1992 - Vol.36 - №3 - Р.356-367.
  6. Oksman P et al. Prevalence and risk factors of diabetic retinopathy according to type of treatment in type 2 diabetic patients // Invest. Ophthalmol. - 1995 - Vol.36 - S1000
  7. Миленькая Т.М., Щербачева Л.Н., Терентьев В.С. Диабетическая ре- тинопатия: диагностика, лечение // Русский медицинский журнал - 2004 - Т.12 - №6 - С. 791-796
  8. Donnelly R. Vascular complications of diabetes // Blackwell Publishing - 2005 - P.189-213.
  9. Porta M, Bandello F. Diabetic retinopathy: a clinical update // Diabetologia - 2002 - Vol.45 - P.1617-1634.
  10. Балашевич ЛИ, Бржеский ВВ и др. Глазные проявления диабета // СпбМАПО - 2004 - С. 123-199.
  11. Tovi J, Ingemansson SO, Engfeldt P. Insulin treatment of elderly type 2 diabetic patients: effect on retinopathy // Diabet Metab - 1998 - Vol.24 - P.442-447.
  12. Chantelau E, Kohner EM. Why some cases of retinopathy worsen when diabetic control improves // British Medical Journal - 1998 - Vol.31 - P.1105-1106.
  13. Klein R, Klein BE et al. The Wisconsin epidemiologic study of Diabetic Retinopathy. XVII. The 14-year incidence and progression of diabetic retinopathy and associated risk factors in type 1 diabetes // Ophthalmology -1998 - Vol.105 - P.1801-1815.
  14. Chaturvedi N, Sjoelie AK, Porta M et al. Markers of insulin resistance are strong risk factors for the incidence of retinopathy in type 1 diabetes: findings from the EURODIAB PCS // Diabetes Care - 2001 - Vol.24 - P.284-289
  15. Araki A, Ito H, Hattori A et al. Risk factors for development of retinopathy in elderly Japanese patients with diabetes mellitus // Diabetes Care - 1993 - Vol.16 - №8 - Р.1184-1186.
  16. Okuno G, Ohki A, Kawakami F, Tako H. Vascular complications in untreated diabetics with obesity during 18 year period // Diabetes Res Clin Practice - 1990 - Vol.10 - №1 - Р.257-262.
  17. Klein R, Klein BE, Moss SE. Is obesity related to microvascular and macrovascular complications in diabetes? The Wisconsin epidemiologic study of Diabetic Retinopathy // Arch. Intern. Med. - 1997 - Vol.157 - №6 - P.650-656.
  18. Klein BE, Moss SE, Klein R et al. The Wisconsin epidemiologic study of Diabetic Retinopathy. XIII. Relationship of serum cholesterol to retinopathy and hard exudate // Ophthalmology - 1991 - Vol.98 - №8 - P.1261-1265.
  19. Early Treatment Diabetic Retinopathy Study Research Group. Fundus photographic risk factors for progression of diabetic retinopathy. ETDRS Report №12 // Ophthalmology - 1991 - Vol.98 - P.823-833
  20. Chew EY, Klein ML, Ferris FL et al. Association of elevated serum lipid levels with retinal hard exudates in diabetic retinopathy. Early Treatment Diabetic Retinopathy Study (ETDRS) Report 22 // Arch Ophthalmol - 1996 - Vol.114 - P.1079-1084
  21. Cruickshanks KJ, Ritter LL, Klein R, Moss SE (1993) The association of microalbuminuria with diabetic retinopathy. The Wisconsin Epidemiologic Study of diabetic retinopathy // Opthalmology - 1993 - Vol.100 - P.862-867
  22. Torffit O, Agardh E, Agard CD. Albuminuria and associated medical risk factors: a cross-sectional study in 476 type 1 diabetic patients. Part 1 // Journal of Diabetic Complications - 1991 - Vol. 5 - №1 - P.23-28.
  23. Stephenson JM, Fuller JH, Viberti GC, Sjolie A-K. Blood pressure, retinopathy and urinary albumin excretion in IDDM: the EURODIAB IDDM Complication Study Group // Diabetologia - 1995 - Vol.38 - P. 599-603.
  24. Chaturvedi N, Sjoelie AK, Stephenson JM et al. Effect of lisinopril on progression of retinopathy in normotensive people with type 1 diabetes. The EUCLID Study Group. EURODIAB Controlled Trial of Lisinopril in Insulin- Dependent Diabetes Mellitus // Lancet - 1998 - Vol.351 - P.28-31
  25. UK Prospective Diabetes Study Gr. XII // Diabetes Medicine - 1994 - Vol.11 - P. 670-677.

Views

Abstract - 593

PDF (Russian) - 919

PlumX


Copyright (c) 2006 Trakhtenberg Y.A., Milen'kaya T.M., Ametov A.S., Demidova T.Y.

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.